| pubmed-article:9322521 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9322521 | lifeskim:mentions | umls-concept:C0033774 | lld:lifeskim |
| pubmed-article:9322521 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:9322521 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
| pubmed-article:9322521 | lifeskim:mentions | umls-concept:C0027360 | lld:lifeskim |
| pubmed-article:9322521 | lifeskim:mentions | umls-concept:C0599724 | lld:lifeskim |
| pubmed-article:9322521 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:9322521 | pubmed:dateCreated | 1997-10-23 | lld:pubmed |
| pubmed-article:9322521 | pubmed:abstractText | The efficacy of currently available therapeutic agents for cholestatic pruritus is often disappointing. The aim of this study was to assess the antipruritic effect of naltrexone, an oral opiate receptor antagonist. | lld:pubmed |
| pubmed-article:9322521 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9322521 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9322521 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:9322521 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9322521 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9322521 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9322521 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9322521 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:9322521 | pubmed:issn | 0016-5085 | lld:pubmed |
| pubmed-article:9322521 | pubmed:author | pubmed-author:VitaliCC | lld:pubmed |
| pubmed-article:9322521 | pubmed:author | pubmed-author:HopW CWC | lld:pubmed |
| pubmed-article:9322521 | pubmed:author | pubmed-author:SternieriEE | lld:pubmed |
| pubmed-article:9322521 | pubmed:author | pubmed-author:BertolottiMM | lld:pubmed |
| pubmed-article:9322521 | pubmed:author | pubmed-author:Van BuurenH... | lld:pubmed |
| pubmed-article:9322521 | pubmed:author | pubmed-author:WolfhagenF... | lld:pubmed |
| pubmed-article:9322521 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9322521 | pubmed:volume | 113 | lld:pubmed |
| pubmed-article:9322521 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9322521 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9322521 | pubmed:pagination | 1264-9 | lld:pubmed |
| pubmed-article:9322521 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9322521 | pubmed:meshHeading | pubmed-meshheading:9322521-... | lld:pubmed |
| pubmed-article:9322521 | pubmed:meshHeading | pubmed-meshheading:9322521-... | lld:pubmed |
| pubmed-article:9322521 | pubmed:meshHeading | pubmed-meshheading:9322521-... | lld:pubmed |
| pubmed-article:9322521 | pubmed:meshHeading | pubmed-meshheading:9322521-... | lld:pubmed |
| pubmed-article:9322521 | pubmed:meshHeading | pubmed-meshheading:9322521-... | lld:pubmed |
| pubmed-article:9322521 | pubmed:meshHeading | pubmed-meshheading:9322521-... | lld:pubmed |
| pubmed-article:9322521 | pubmed:meshHeading | pubmed-meshheading:9322521-... | lld:pubmed |
| pubmed-article:9322521 | pubmed:meshHeading | pubmed-meshheading:9322521-... | lld:pubmed |
| pubmed-article:9322521 | pubmed:meshHeading | pubmed-meshheading:9322521-... | lld:pubmed |
| pubmed-article:9322521 | pubmed:meshHeading | pubmed-meshheading:9322521-... | lld:pubmed |
| pubmed-article:9322521 | pubmed:meshHeading | pubmed-meshheading:9322521-... | lld:pubmed |
| pubmed-article:9322521 | pubmed:meshHeading | pubmed-meshheading:9322521-... | lld:pubmed |
| pubmed-article:9322521 | pubmed:meshHeading | pubmed-meshheading:9322521-... | lld:pubmed |
| pubmed-article:9322521 | pubmed:meshHeading | pubmed-meshheading:9322521-... | lld:pubmed |
| pubmed-article:9322521 | pubmed:meshHeading | pubmed-meshheading:9322521-... | lld:pubmed |
| pubmed-article:9322521 | pubmed:meshHeading | pubmed-meshheading:9322521-... | lld:pubmed |
| pubmed-article:9322521 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9322521 | pubmed:articleTitle | Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study. | lld:pubmed |
| pubmed-article:9322521 | pubmed:affiliation | Department of Hepatogastroenterology, University Hospital Rotterdam-Dijkzigt, The Netherlands. | lld:pubmed |
| pubmed-article:9322521 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9322521 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:9322521 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:9322521 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:9322521 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9322521 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9322521 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9322521 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9322521 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9322521 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9322521 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9322521 | lld:pubmed |
